Pasithea Therapeutics Corp. financial data

Symbol
KTTA, KTTAW on Nasdaq
Location
1111 Lincoln Road, Suite 500, Miami Beach, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 624 % -10.1%
Debt-to-equity 9.25 % -9.94%
Return On Equity -88.6 % -18.7%
Return On Assets -81.1 % -19.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.44M shares +613%
Common Stock, Shares, Outstanding 7.44M shares +613%
Entity Public Float 4.1M USD -61%
Common Stock, Value, Issued 743 USD +614%
Weighted Average Number of Shares Outstanding, Basic 5.64M shares +441%
Weighted Average Number of Shares Outstanding, Diluted 5.64M shares +441%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6.97M USD -23.3%
General and Administrative Expense 1.66M USD +4.74%
Operating Income (Loss) -13.8M USD +18.7%
Nonoperating Income (Expense) 298K USD -46%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -13.5M USD +17.8%
Net Income (Loss) Attributable to Parent -13.5M USD +17.9%
Earnings Per Share, Basic -0.66 USD/shares +82.2%
Earnings Per Share, Diluted -0.66 USD/shares +82.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.22M USD -9.42%
Other Assets, Current 118K USD +12.6%
Assets, Current 8.64M USD -0.07%
Property, Plant and Equipment, Net 114K USD -13.8%
Operating Lease, Right-of-Use Asset 32K USD -93%
Intangible Assets, Net (Excluding Goodwill) 7M USD -8.26%
Goodwill 1.26M USD 0%
Assets 17M USD -3.7%
Liabilities, Current 1.74M USD +24.5%
Operating Lease, Liability, Noncurrent 211K USD -70.9%
Liabilities 1.83M USD +23%
Accumulated Other Comprehensive Income (Loss), Net of Tax 5.63K USD
Retained Earnings (Accumulated Deficit) -56.9M USD -32.1%
Stockholders' Equity Attributable to Parent 15.2M USD -6.16%
Liabilities and Equity 17M USD -3.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.06M USD +29.3%
Net Cash Provided by (Used in) Financing Activities 1.47M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 7.44M shares +613%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.58M USD +63.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.22M USD -9.42%
Interest Paid, Excluding Capitalized Interest, Operating Activities 7.89K USD
Deferred Tax Assets, Valuation Allowance 0 USD
Deferred Tax Assets, Gross 11.8M USD +54.6%
Operating Lease, Liability 33K USD -92.9%
Depreciation 4K USD -20%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.5M USD +17.9%
Lessee, Operating Lease, Liability, to be Paid 33.3K USD
Property, Plant and Equipment, Gross 162K USD -1.94%
Operating Lease, Liability, Current 33K USD -80%
Lessee, Operating Lease, Liability, to be Paid, Year Two 183K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 83.3K USD -72%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 323 USD -99.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 72M USD +21.6%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 11.7M USD +53.6%
Share-based Payment Arrangement, Expense 97K USD -67.5%
Operating Leases, Future Minimum Payments Due 83.3K USD
Interest Expense -117K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%